|
US6902738B2
|
|
Topical oral dosage forms containing bismuth compounds
|
|
US6426085B1
|
|
Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
|
|
US6372784B1
|
|
Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
|
|
US5834002A
|
|
Chewing gum containing colloidal bismuth subcitrate
|
|
IL117751D0
|
|
Oral topical dosage form of a bismuth compound for treatment of helicobacter pylori in an oral cavity
|
|
AU5439696A
|
|
Bismuth-containing compounds in topical dosage forms
|
|
EP1683515A2
|
|
Bismuth-containing compounds in topical dosage forms
|
